Hemostatic Disorders  >>  Octagam (intravenous normal human immunoglobulin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Octagam (intravenous normal human immunoglobulin) / Octapharma
NCT00426270 / 2005-003552-35: Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Completed
3
116
Europe
Octagam 10%, Human normal immunoglobulin
Octapharma
Immune Thrombocytopenic Purpura
09/08
09/08

Download Options